Dr Amelia McGuinness specialises in microbiome science. Since starting her PhD in 2016, she has been exploring how microbiomes influence human health and disease.
While often associated with gut health, microbiomes impact everything from immune function and mental health to agriculture and climate science. Currently, her focus is on manipulating the gut microbiome through faecal microbiome transplantation and diet to better understand chronic conditions like depression, Long COVID, chronic pelvic pain, and recurrent urinary tract infections.
Why are you passionate about this field of research?
I am particularly passionate about this research as each of the chronic conditions I focus on disproportionately affect women and currently have limited effective and evidence- based treatment options.
I was drawn to microbiome science because of its potential to transform how we approach chronic disease. Unlike traditional medicine, which often focuses on symptom management, microbiome research opens the door to more personalised treatment options that may actually target the underlying disease mechanisms.
My work aims to uncover how we can harness the microbiome to improve conditions like depression, chronic pelvic pain, and Long COVID. These illnesses are often overlooked or misunderstood, particularly in women’s health, and my goal is to contribute to new, evidence-based therapeutic strategies that improve quality of life.
What is the potential impact of your research?
The potential impact of my research is significant – microbiome-targeted interventions have the power to transform healthcare. By exploring how the gut microbiome influences mental health, immune function, and chronic disease, my work could lead to novel, non-pharmacological treatments for conditions like depression, chronic pain, and Long COVID. These conditions affect millions globally, often with limited treatment options.
My research also emphasises consumer involvement, ensuring real-world relevance. By bridging microbiome science with clinical applications, I hope to contribute to more personalised and effective healthcare solutions, improving outcomes for individuals and communities.
What does a typical working week look like for you?
My work involves running clinical trials, analysing data, and developing new research ideas. It’s fast-paced, sometimes chaotic, but incredibly rewarding.
What do your collaborations look like?
Collaboration is at the heart of everything I do. I strongly believe in networking and bringing together the right people, particularly for grants. Over the past 12 months, I have successfully engaged more than 30 new researchers across multiple grant projects, forging partnerships that have been instrumental in securing funding.
Beyond academia, I have built ongoing collaborations with industry, healthcare, schools, and not-for-profits, all of which have strengthened my research and impacted my grant success. Most importantly, working with consumers and individuals with lived experience has been one of the most rewarding aspects of my career, and I will continue to commit myself to co-design to shape my research in meaningful and impactful ways.
Tell us about some of your recent career highlights.
A major highlight of 2024 was securing three MRFF grants, two of which I led as Chief Investigator A – an achievement I’m incredibly proud of, particularly so early in my career.
These grants have not only boosted my confidence but also allowed me to build a research team, establish new collaborations, and take significant steps toward an independent research career.
Winning these grants has been both rewarding and humbling, reflecting the incredible support, mentorship, and collegiality I’ve received at IMPACT. The experience has reinforced my passion for research and my commitment to making meaningful contributions to health and science.
How will your research evolve over the coming year?
In 2025, my priority is successfully running the clinical trials I was funded for – ensuring smooth implementation and high-quality data collection. Beyond this, I want to become more active in: advocating for a national microbiome initiative, influencing policy, and engaging with government to drive recognition of the microbiome’s role in health and disease.
I’m passionate about supporting PhD students and early-career researchers, whether through mentorship, collaboration, or simply sharing advice. Navigating academia can be challenging, and I believe in fostering a supportive research community. I’m always open to connecting with others in the field and helping them develop their research careers.
